Combo method reveals cells' signal systems

May 25, 2011 in Cancer

Our understanding of what differentiates cancer cells from normal cells is limited by a lack of methods for studying the complex signal systems of individual cells. By combing two different methods, a team of Uppsala researchers have now provided the research world with a tool for studying signal paths on several levels at the same time. Their article is being published today in PLoS One.

"We also show that the method can be used to determine the molecular effect of drugs or pharmaceuticals," says Ola Söderberg, who directed the study at the Department of Immunology, Genetics, and Pathology, Uppsala University.

Interaction between separate is crucial for the body to function. Cells communicate with each other through direct contact and through soluble substances/molecules that are sent out as a "signal" to surrounding cells. When they bind to a receptor molecule on another cell, the signal is further transmitted into that cell by a relay of protein interactions, thereby regulating mRNA expression. between and within cells is a highly complex process that is regulated on several different levels in the signal pathways.

"What's more, signaling can differ considerably between one cell and a neighbor cell, so the possibility of studying the signaling of individual cells is extremely important for us to understand various pathological conditions, such as cancer," says Ola Söderberg.

It is the lack of methods for doing so that has limited our understanding of what differentiates from normal cells. The new method combines two different methods that reveal protein activity and mRNA expression, respectively. This makes it possible to determine the direction of signal, that is, what the effect of signaling is. The two methods that are now being combined were developed over the last few years by this same research team.

"The possibility of now combining them will yield a clearer picture of what went wrong in cancer cells, and it will lead to greater insight into how cancer cells work together with and exploit normal cells."

In the article, the methods are used to see how quickly signals are transmitted, from the surface of cells to the nucleus, and to determine how many of the cells respond to the signals. Further, the methods can be used to understand how various drugs function and where they disrupt signaling, and will facilitate the discovery of new targeted pharmaceuticals to treat cancer.

Provided by Uppsala University search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

ASCO: combo antibody therapy effective for melanoma

(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...

Cancer created 14 hours ago | popularity not rated yet | comments 0

Risk factors ID'd for poor cutaneous cell CA outcomes

(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond ...

Cancer created 15 hours ago | popularity not rated yet | comments 0 | with audio podcast

Physical & emotional impairments common, often untreated in people with cancer

A new review finds cancer survivors suffer a diverse and complex set of impairments, affecting virtually every organ system. Writing in CA: A Cancer Journal for Clinicians, Julie Silver, M.D., associate professor at Harvar ...

Cancer created 19 hours ago | popularity not rated yet | comments 0

Calif. doc with 'cancer cure' gets 14 years prison (Update)

(AP)—A California doctor has been sentenced to 14 years in federal prison for bilking her patients out of more than $1 million by promising that an herbal supplement could cure late-stage cancer and other diseases.

Cancer created 20 hours ago | popularity not rated yet | comments 0

New protein-targeting drug shows promise in early trial for patients with high-risk CLL

A new oral targeted drug, idelalisib (GS-1101), has the potential to stave off the need for additional treatments for relapsed or treatment-resistant chronic lymphocytic leukemia (CLL), according to a study led in part by ...

Cancer created 21 hours ago | popularity not rated yet | comments 0 | with audio podcast


AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests

Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...

Melon focus headband turns to Kickstarter for rollout plans

(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...

Temporal processing in the olfactory system

The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...

Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria

In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...

Individuals who drink heavily and smoke may show 'early aging' of the brain

Treatment for alcohol use disorders works best if the patient actively understands and incorporates the interventions provided in the clinic. Multiple factors can influence both the type and degree of neurocognitive abnormalities ...